Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C1-inhibitor to improve red blood cell transfusion efficacy in autoimmune hemolytic anemia
NL-OMON55361Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of c1-esterase inhibitor in autoimmune haemolytic anaemia (AIHA), sponsored by Amsterdam University Medical Center. Primary endpoints: Improvement of red blood cell transfusion recovery, Inhibition of classical complement activation on red blood cells and 1 more. Started Jun 2014; status: active, not recruiting.
02
Drugs
c1-esterase inhibitor
03
Conditions
autoimmune haemolytic anaemia (AIHA)
Beyond the preview
Go deeper on NL-OMON55361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55361.